234 related articles for article (PubMed ID: 26356817)
1. An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC.
Yang S; Cho YJ; Jin L; Yuan G; Datta A; Buckhaults P; Datta PK
Oncotarget; 2015 Oct; 6(32):33237-52. PubMed ID: 26356817
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
[TBL] [Abstract][Full Text] [Related]
3. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.
Anumanthan G; Halder SK; Osada H; Takahashi T; Massion PP; Carbone DP; Datta PK
Br J Cancer; 2005 Nov; 93(10):1157-67. PubMed ID: 16251876
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
[TBL] [Abstract][Full Text] [Related]
5. TGF-β-SMAD-miR-520e axis regulates NSCLC metastasis through a TGFBR2-mediated negative-feedback loop.
Kucuksayan H; Akgun S; Ozes ON; Alikanoglu AS; Yildiz M; Dal E; Akca H
Carcinogenesis; 2019 Jul; 40(5):695-705. PubMed ID: 30475986
[TBL] [Abstract][Full Text] [Related]
6. MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC.
Jiang Z; Yin J; Fu W; Mo Y; Pan Y; Dai L; Huang H; Li S; Zhao J
PLoS One; 2014; 9(4):e94639. PubMed ID: 24722426
[TBL] [Abstract][Full Text] [Related]
7. Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231.
De S; Das S; Mukherjee S; Das S; Sengupta Bandyopadhyay S
Exp Cell Res; 2017 Dec; 361(1):85-92. PubMed ID: 28987542
[TBL] [Abstract][Full Text] [Related]
8. Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer.
Zhang HT; Chen XF; Wang MH; Wang JC; Qi QY; Zhang RM; Xu WQ; Fei QY; Wang F; Cheng QQ; Chen F; Zhu CS; Tao SH; Luo Z
Clin Cancer Res; 2004 Apr; 10(7):2359-67. PubMed ID: 15073112
[TBL] [Abstract][Full Text] [Related]
9. Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer.
Chaniad P; Trakunran K; Geater SL; Keeratichananont W; Thongsuksai P; Raungrut P
PLoS One; 2020; 15(10):e0241593. PubMed ID: 33125430
[TBL] [Abstract][Full Text] [Related]
10. The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis.
Zu L; Xue Y; Wang J; Fu Y; Wang X; Xiao G; Hao M; Sun X; Wang Y; Fu G; Wang J
Carcinogenesis; 2016 Mar; 37(3):333-343. PubMed ID: 26818357
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of TGF-b1, TGF-b receptor 2, and TGF-b-associated microRNAs, miR-20a and miR-21, in skin lesions of sulfur mustard-exposed Iranian war veterans.
Valizadeh M; Mirzaei B; Tavallaei M; Noorani MR; Amiri M; Soroush MR; Mowla SJ
J Recept Signal Transduct Res; 2015; 35(6):634-9. PubMed ID: 26498464
[TBL] [Abstract][Full Text] [Related]
12. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II.
Song K; Krebs TL; Danielpour D
J Biol Chem; 2006 Mar; 281(12):7765-74. PubMed ID: 16428382
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-20b promotes cell proliferation via targeting of TGF-β receptor II and upregulates MYC expression in Ewing's sarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Int J Oncol; 2017 Dec; 51(6):1842-1850. PubMed ID: 29039480
[TBL] [Abstract][Full Text] [Related]
14. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
[TBL] [Abstract][Full Text] [Related]
15. A novel molecular pathway for Snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis.
Grant JL; Fishbein MC; Hong LS; Krysan K; Minna JD; Shay JW; Walser TC; Dubinett SM
Cancer Prev Res (Phila); 2014 Jan; 7(1):150-60. PubMed ID: 24253315
[TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
[TBL] [Abstract][Full Text] [Related]
17. TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity.
Finger EC; Turley RS; Dong M; How T; Fields TA; Blobe GC
Carcinogenesis; 2008 Mar; 29(3):528-35. PubMed ID: 18174241
[TBL] [Abstract][Full Text] [Related]
18. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
19. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.
Knaus PI; Lindemann D; DeCoteau JF; Perlman R; Yankelev H; Hille M; Kadin ME; Lodish HF
Mol Cell Biol; 1996 Jul; 16(7):3480-9. PubMed ID: 8668164
[TBL] [Abstract][Full Text] [Related]
20. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
